Health related quality of life outcomes for unresectable stage III or IV melanoma patients receiving ipilimumab treatment

von Revicki Dennis A, van den Eertwegh Alfons JM, Lorigan Paul, Lebbe Celeste, Linette Gerald, Ottensmeier Christian H, Safikhani Shima, Messina Marianne, Hoos Axel, Wagner Samuel, Kotapati Srividya
Veröffentlicht 2012-06-01

Health related quality of life outcomes for unresectable stage III or IV melanoma patients receiving ipilimumab treatment

von Revicki, Dennis A, van den Eertwegh, Alfons JM, Lorigan, Paul, Lebbe, Celeste, Linette, Gerald, Ottensmeier, Christian H, Safikhani, Shima, Messina, Marianne, Hoos, Axel, Wagner, Samuel, Kotapati, Srividya
Veröffentlicht 2012

Tumor-mediated inhibition of human dendritic cell differentiation and function is consistently counteracted by combined p38 MAPK and STAT3 inhibition

von Oosterhoff, Dinja, Lougheed, Sinéad, van de Ven, Rieneke, Lindenberg, Jelle, van Cruijsen, Hester, Hiddingh, Lotte, Kroon, Jan, van den Eertwegh, Alfons J.M., Hangalapura, Basav, Scheper, Rik J., de Gruijl, Tanja D.
Veröffentlicht 2012

Induction of dendritic cell maturation in the skin microenvironment by soluble factors derived from colon carcinoma

von Lindenberg, Jelle J, van de Ven, Rieneke, Oosterhoff, Dinja, Sombroek, Claudia C, Lougheed, Sinéad M, Stam, Anita GM, Koenen, Hans JPM, van den Eertwegh, Alfons JM, Scheper, Rik J, de Gruijl, Tanja D
Veröffentlicht in Hum Vaccin Immunother (2014)

Myeloid derived suppressor and dendritic cell subsets are related to clinical outcome in prostate cancer patients treated with prostate GVAX and ipilimumab

von Santegoets, Saskia JAM, Stam, Anita GM, Lougheed, Sinéad M, Gall, Helen, Jooss, Karin, Sacks, Natalie, Hege, Kristen, Lowy, Israel, Scheper, Rik J, Gerritsen, Winald R, van den Eertwegh, Alfons JM, de Gruijl, Tanja D
Veröffentlicht in J Immunother Cancer (2014)

Vemurafenib plus cobimetinib in unresectable stage IIIc or stage IV melanoma: response monitoring and resistance prediction with positron emission tomography and tumor characterist...

von van der Hiel, Bernies, Haanen, John B.A.G., Stokkel, Marcel P.M., Peeper, Daniel S., Jimenez, Connie R., Beijnen, Jos H., van de Wiel, Bart A., Boellaard, Ronald, van den Eertwegh, Alfons J.M.
Veröffentlicht in BMC Cancer (2017)

Delivery route, MyD88 signaling and cross-priming events determine the anti-tumor efficacy of an Adenovirus based melanoma vaccine

von Hangalapura, Basav N, Oosterhoff, Dinja, Gupta, Tarun, de Groot, Jan, Wijnands, Pepijn GJTB, van Beusechem, Victor W., den Haan, Joke, Tüting, Thomas, van den Eertwegh, Alfons JM, Curiel, David T, Scheper, Rik J, de Gruijl, Tanja D
Veröffentlicht 2011

IL-21 promotes the expansion of CD27(+)CD28(+) tumor infiltrating lymphocytes with high cytotoxic potential and low collateral expansion of regulatory T cells

von Santegoets, Saskia JAM, Turksma, Annelies W, Suhoski, Megan M, Stam, Anita GM, Albelda, Steve M, Hooijberg, Erik, Scheper, Rik J, van den Eertwegh, Alfons JM, Gerritsen, Winald R, Powell, Daniel J, June, Carl H, de Gruijl, Tanja D
Veröffentlicht 2013

Functional characterization of a STAT3-dependent dendritic cell-derived CD14(+) cell population arising upon IL-10-driven maturation

von Lindenberg, Jelle J., van de Ven, Rieneke, Lougheed, Sinéad M., Zomer, Anoek, Santegoets, Saskia J.A.M., Griffioen, Arjan W., Hooijberg, Erik, van den Eertwegh, Alfons J.M., Thijssen, Victor L., Scheper, Rik J., Oosterhoff, Dinja, de Gruijl, Tanja D.
Veröffentlicht 2013

Improvements in Radiographic Progression-Free Survival Stratified by ERG Gene Status in Castration-Resistant Prostate Cancer Patients Treated with Abiraterone

von Attard, Gerhardt, de Bono, Johann S., Logothetis, Christopher J., Fizazi, Karim, Mukherjee, Som D., Joshua, Anthony M., Schrijvers, Dirk, van den Eertwegh, Alfons J.M., Li, Weimin, Molina, Arturo, Griffin, Thomas W., Kheoh, Thian, Ricci, Deborah S., Zelinsky, Kathy, Rathkopf, Dana E., Scher, Howard I., Ryan, Charles J.
Veröffentlicht in Clin Cancer Res (2015)

T cell infiltration on local CpG-B delivery in early-stage melanoma is predominantly related to CLEC9A(+)CD141(+) cDC1 and CD14(+) antigen-presenting cell recruitment

von Koster, Bas D, López González, Marta, van den Hout, Mari FCM, Turksma, Annelies W, Sluijter, Berbel JR, Molenkamp, Barbara G, van Leeuwen, Paul AM, Vosslamber, Saskia, Scheper, Rik J, van den Eertwegh, Alfons JM, van den Tol, M Petrousjka, Jordanova, Ekaterina J, de Gruijl, Tanja D
Veröffentlicht in J Immunother Cancer (2021)

Development of thyroglobulin antibodies after GVAX immunotherapy is associated with prolonged survival

von De Remigis, Alessandra, de Gruijl, Tanja D, Uram, Jennifer N, Tzou, Schey-Cherng, Iwama, Shintaro, Talor, Monica V, Armstrong, Todd D, Santegoets, Saskia J A M, Slovin, Susan F, Zheng, Lei, Laheru, Daniel A, Jaffee, Elizabeth M, Gerritsen, Winald R, van den Eertwegh, Alfons JM, Le, Dung T, Caturegli, Patrizio
Veröffentlicht 2014

Improved Survival with Ipilimumab in Patients with Metastatic Melanoma

von Hodi, F. Stephen, O’Day, Steven J., McDermott, David F., Weber, Robert W., Sosman, Jeffrey A., Haanen, John B., Gonzalez, Rene, Robert, Caroline, Schadendorf, Dirk, Hassel, Jessica C., Akerley, Wallace, van den Eertwegh, Alfons J.M., Lutzky, Jose, Lorigan, Paul, Vaubel, Julia M., Linette, Gerald P., Hogg, David, Ottensmeier, Christian H., Lebbé, Celeste, Peschel, Christian, Quirt, Ian, Clark, Joseph I., Wolchok, Jedd D., Weber, Jeffrey S., Tian, Jason, Yellin, Michael J., Nichol, Geoffrey M., Hoos, Axel, Urba, Walter J.
Veröffentlicht 2010

Switching to Immune Checkpoint Inhibitors upon Response to Targeted Therapy; The Road to Long-Term Survival in Advanced Melanoma Patients with Highly Elevated Serum LDH?

von Schouwenburg, Maartje G., Suijkerbuijk, Karijn P.M., Koornstra, Rutger H.T., Jochems, Anouk, van Zeijl, Michiel C.T., van den Eertwegh, Alfons J.M., Haanen, John B.A.G., Aarts, Maureen J.B., van Akkooi, Alexander C.J., van den Berkmortel, Franchette W.P.J., de Groot, Jan Willem B., Hospers, Geke A.P., Kapiteijn, Ellen, Kruit, Wim H., Piersma, Djura, van Rijn, Rozemarijn S., ten Tije, Albert J., Vreugdenhil, Gerard, van der Hoeven, Jacobus J.M., Wouters, Michel W.J.M.
Veröffentlicht in Cancers (Basel) (2019)